Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Management of bladder dysfunction in patients with multiple sclerosis.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Severe relapses under fingolimod treatment prescribed after natalizumab.
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Bipolar disorder and multiple sclerosis: a case series.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.
Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.
Outcomes after Percutaneous Surgery for Patients with Multiple Sclerosis Related Trigeminal Neuralgia.
Is metabolic flexibility altered in multiple sclerosis patients?
Cognitive impairment among different clinical courses of multiple sclerosis.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Clinical profile and short-term outcomes of optic neuritis patients in India.
Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer Thickness in NMO Patients.
Pages
« first
‹ previous
…
323
324
325
326
327
328
329
330
331
…
next ›
last »